Search Results - "Pérez‐Ceballos, E."
-
1
Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin’s lymphoma in patients older than 50 years
Published in Annals of hematology (2017)“…Autologous hematopoietic cell transplantation (AHCT) is the standard of care for young patients with relapsed/refractory (R/R) Hodgkin’s lymphoma (HL)…”
Get full text
Journal Article -
2
P1137: ACCURACY AND PROGNOSTIC IMPACT OF FDG PET/CT AND BIOPSY IN BONE MARROW ASSESSMENT OF FOLLICULAR LYMPHOMA AT DIAGNOSIS: A NATION‐WIDE STUDY
Published in HemaSphere (23-06-2022)Get full text
Journal Article -
3
-
4
Evaluation of refrigerated platelet concentrates supplemented with low doses of second messenger effectors
Published in Clinical and laboratory haematology (01-08-2004)“…Summary With the goal of producing haemostatically effective platelet concentrates (PCs) with a longer shelf‐life, we aimed to identify a simple combination of…”
Get full text
Journal Article -
5
-
6
P1128: CLINICAL FEATURES AND OUTCOME OF PATIENTS WITH CASTLEMAN DISEASE: A SPANISH MULTICENTRIC STUDY OF 134 PATIENTS FROM GELTAMO
Published in HemaSphere (23-06-2022)Get full text
Journal Article -
7
-
8
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
Published in Hematological oncology (01-06-2023)Get full text
Journal Article -
9
Bam Regimen Followed By High-Dose Therapy and Autologous Stem Cell Transplantation As First-Line Treatment Of Primary Central Nervous System Lymphoma: A Multicenter Study From Spanish Group GEL-TAMO
Published in Blood (15-11-2013)“…Primary central nervous system lymphoma (PCNSL) is a rare malignancy with peculiar clinical and biologic features, aggressive course, and unsatisfactory…”
Get full text
Journal Article -
10
Administration of post-autologous PBSCT rhG-CSF is associated with long-term low concentrations of bone marrow hematopoietic progenitor cells
Published in Bone marrow transplantation (Basingstoke) (01-06-2001)“…Recombinant human granulocyte colony-stimulating factor (rhG-CSF) has been widely used after autologous peripheral blood stem cell transplant (APBSCT) in an…”
Get full text
Journal Article -
11
Fatal upper and lower gastrointestinal cytomegalovirus disease following autologous peripheral blood stem cell transplantation
Published in European journal of haematology (01-02-2001)“…Although the life-threatening cytomegalovirus (CMV) disease is a well known complication following allogeneic hematopoietic stem cell transplantation (HSCT),…”
Get full text
Journal Article -
12
Prothrombin A19911G and G20210A polymorphisms' role in thrombosis
Published in British journal of haematology (01-08-2002)“…The prothrombin G20210A polymorphism, which correlates with the plasmatic prothombin levels, is the second genetic risk factor for deep venous thrombosis…”
Get full text
Journal Article -
13
Protein Z‐dependent protease inhibitor W303X mutation in venous thrombosis
Published in British journal of haematology (01-05-2005)Get full text
Journal Article -
14
Combination Chemotherapy with Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) Induces a High Response Rate in Previously Untreated CLL
Published in Blood (16-11-2005)“…Treatment with FCM results in responses rates of 60% in relapsed or refractory CLL patients. Against this background, we started a trial of FCM in untreated…”
Get full text
Journal Article -
15
Evaluation of a new whole-blood filter that allows preparation of platelet concentrates by platelet-rich plasma methods
Published in Transfusion (Philadelphia, Pa.) (01-12-2003)“…BACKGROUND: A novel WBC‐reduction in‐line whole‐blood (WB) filter that does not retain platelets was evaluated to assess the filtration performance and, after…”
Get full text
Journal Article -
16
Fatal upper and lower gastrointestinal cytomegalovirus disease following autologous peripheral blood stem cell transplantation
Published in European journal of haematology (01-02-2001)“…: Although the life‐threatening cytomegalovirus (CMV) disease is a well known complication following allogeneic hematopoietic stem cell transplantation (HSCT),…”
Get full text
Journal Article -
17